Praveen P. Govender MB BCh

Assistant Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine

72 E. Concord Street | (617) 638-4814
Praveen Govender
Sections

Pulmonary, Allergy, Sleep & Critical Care Medicine

Centers

Pulmonary Center

Biography

Dr. Praveen Govender is the Associate Director of the Sarcoidosis Center with training in Pulmonary Medicine, Allergy and Immunology. He has worked extensively with Dr. Jeffrey Berman in the care of patients with sarcoidosis since 2008 at The Sarcoidosis Center at Boston Medical Center. Their mission is to improve the lives of persons with sarcoidosis by providing state-of-the-art patient care coupled with innovative research aimed at understanding the pathogenesis and natural history of sarcoidosis. Dr. Govender is an active member of the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG).

Education

MBBCh, Royal College of Surgeons in Ireland

BS, University of Alberta

Publications

Published on 11/9/2024

Sangani R, Bosch NA, Govender P, Scarpato B, Walkey AJ, Newman J, Law AC, Gillmeyer KR, Shankar DA. Sarcoidosis Treatment Patterns in the United States: 2016-2022. Chest. 2024 Nov 09. PMID: 39522595.

Published on 6/6/2023

Halpin M, Lerner A, Sagar M, Govender P, Shah B, Weinberg J, Sarosiek S, Sloan JM. A prospective, single-center, randomized phase 2 trial of etoposide in severe COVID-19. medRxiv. 2023 Jun 06. PMID: 37333402.

Published on 11/1/2022

Cozier YC, Govender P, Berman JS. Obesity and Sarcoidosis Risk: An Index Under Suspicion. Chest. 2022 Nov; 162(5):954-956. PMID: 36344120.

Published on 2/22/2021

Lui JK, Mesfin N, Tugal D, Klings ES, Govender P, Berman JS. Critical Care of Patients With Cardiopulmonary Complications of Sarcoidosis. J Intensive Care Med. 2022 Apr; 37(4):441-458. PMID: 33611981.

Published on 10/1/2020

Law ST, Jafarzadeh SR, Govender P, Sun X, Sanchorawala V, Kissin EY. Comparison of Ultrasound Features of Major Salivary Glands in Sarcoidosis, Amyloidosis, and Sjögren's Syndrome. Arthritis Care Res (Hoboken). 2020 10; 72(10):1466-1473. PMID: 31309727.

Published on 9/3/2020

Govender P, Cozier YC. Sarcoidosis in a time of pandemic. Eur Respir J. 2020 09; 56(3). PMID: 32883761.

Published on 6/30/2020

Abston E, Moll M, Hon S, Govender P, Berman J, Farber H. Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertension. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):184-191. PMID: 33093782.

Published on 6/30/2020

Abston E, Hon S, Lawrence R, Berman J, Govender P, Farber HW. Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):234-238. PMID: 33093789.

Published on 6/30/2020

Nitzberg M, Parikh R, Govender P, Farber HW. Pulmonary hypertension secondary to takayasu's arteritis: management using a combined medical and interventional approach. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):239-241. PMID: 33093790.

Published on 4/15/2020

Cozier YC, Govender P. Sarcoidosis: An Ill-afforded Disease. Am J Respir Crit Care Med. 2020 04 15; 201(8):890-891. PMID: 31978312.

View full list of 24 publications.